RecruitingNot applicableNCT07374289
On Scene ECPR in Ostrava
Studying Cardiogenic shock
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital Ostrava
- Principal Investigator
- Filip Burša, MD, PhD, EDECUniversity Hospital Ostrava
- Intervention
- Prehospital ECMO cannulation on scene of cardiac arrest(procedure)
- Enrollment
- 90 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2026 – 2029
Study locations (2)
- Emergency Medical Services, Moravian-Silesian Region, Ostrava, Moravian-Silesian Region, Czechia
- University Hospital Ostrava, Ostrava, Moravian-Silesian Region, Czechia
Collaborators
Emergency Medical Services, Moravian-Silesian Region
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07374289 on ClinicalTrials.govOther trials for Cardiogenic shock
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07527156Prolonged Nasogastric Administration of Ketones in Decompensated Heart FailureInstitute for Clinical and Experimental Medicine
- RECRUITINGNANCT07345559Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic ShockCMC Ambroise Paré
- RECRUITINGNCT07402018Intra-aortic Balloon Counterpulsation (IABC) ComplianceThomas Jefferson University
- RECRUITINGNCT07309029Pre-Emptive LAVA-ECMO for Complex High-Risk TAVRAtlantic Health System
- RECRUITINGNANCT07293923Magenta Elevate™ Clinical Feasibility Study in Cardiogenic ShockMagenta Medical Ltd.
- RECRUITINGNCT07354568Prognosis of Patients With Mixed Cardiogenic-Vasoplegic ShockCentre Hospitalier Universitaire, Amiens
- RECRUITINGNCT06964685Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic ShockAbiomed Inc.
- ACTIVE NOT RECRUITINGNANCT07141355Empagliflozin's Microcirculatory Effects in Cardiogenic Shock: an Ancillary Pilot Study of the EMPASHOCK TrialUniversity Hospital, Strasbourg, France